Markets:

Overview

News

Currencies

International

Treasuries

Quince Therapeutics, Inc. - Common Stock (NQ:QNCX)

1.800 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Quince Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Quince Therapeutics Appoints Dr. Charles S. Ryan as President

September 06, 2023

From Quince Therapeutics, Inc.

Via Business Wire

Quince Therapeutics And 2 Other Stocks Under $3 Insiders Are Buying ↗

August 14, 2023

The Dow Jones closed higher by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

Quince Therapeutics to Present at Sidoti Virtual Investor Conference on August 17, 2023

August 10, 2023

From Quince Therapeutics, Inc.

Via Business Wire

What's Going On With Quince Therapeutics Stock Today ↗

July 24, 2023

Quince Therapeutics Inc (NASDAQ: QNCX) has agreed to acquire EryDel SpA, a privately-held, late-stage biotech company, in a stock-for-stock upfront exchange and potential downstream

Via Benzinga

Echo Lake Criticizes Quince Therapeutics Board for Enriching Themselves While Destroying Significant Shareholder Value

June 06, 2023

Via ACCESSWIRE

Biomed Industries, Inc. Offers to Acquire Quince Therapeutics, Inc.

May 03, 2023

Via ACCESSWIRE

Echo Lake Capital Offers to Acquire Quince Therapeutics, Inc.

March 21, 2023

Via ACCESSWIRE

Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 24, 2023

Gainers Tupperware Brands Corporation (NYSE: TUP) shares jumped 59% to $1.43 on above-average volume amid retail investor interest.

Via Benzinga

Quince Therapeutics to Acquire EryDel SpA and its Phase 3 Asset Targeting Ataxia-Telangiectasia with No Currently Approved Treatments and Estimated $1+ Billion Peak Sales Opportunity

July 24, 2023

From Quince Therapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 13, 2023

Via Benzinga

Echo Lake Capital Increase Offer to Acquire Quince Therapeutics, Inc.

July 13, 2023

Via ACCESSWIRE

Quince Therapeutics Board of Directors Unanimously Rejects Unsolicited Proposal from Echo Lake Capital

April 11, 2023

From Quince Therapeutics, Inc.

Via Business Wire

Quince Therapeutics Engages MTS Health Partners as Independent Financial Advisor

April 06, 2023

From Quince Therapeutics, Inc.

Via Business Wire

Quince Therapeutics Adopts Limited Duration Stockholders Rights Plan

April 05, 2023

From Quince Therapeutics, Inc.

Via Business Wire

Quince Therapeutics Confirms Receipt of Unsolicited Acquisition Offer from Echo Lake Capital

March 22, 2023

From Quince Therapeutics, Inc.

Via Business Wire

Nasdaq Up Over 100 Points; Crude Oil Rises 2% ↗

March 21, 2023

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Tuesday. The Dow traded up 0.41% to 32,376.61 while the NASDAQ rose 1.05% to 11,798.39....

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 21, 2023

Via Benzinga

Why Citi Trends Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 21, 2023

Gainers U.S. Xpress Enterprises, Inc. (NYSE: USX) shares surged 298% to $5.97 after Knight-Swift Transportation agreed to acquire the company for $6.15 per share.

Via Benzinga

Gold Drops Over 1%; Existing Home Sales Surge In February ↗

March 21, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Tuesday. The Dow traded up 0.65% to 32,455.57 while the NASDAQ rose 0.57% to 11,741.91. The S&P 500,...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 21, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 15, 2023

Via Benzinga

Quince Therapeutics Provides Pipeline Update and Business Outlook for 2023

January 30, 2023

From Quince Therapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 30, 2023

Via Benzinga

Why Heart Test Laboratories Are Trading Higher By 136%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 30, 2023

Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares surged 136% to $2.06 after Ascendant Capital initiated coverage on the stock with a Buy rating and a $3.30 price target.

Via Benzinga

Why CN Energy Group Shares Are Trading Lower By 47%; Here Are 20 Stocks Moving Premarket ↗

January 30, 2023

Gainers BigBear.ai Holdings, Inc. (NYSE: BBAI) shares rose 45.4% to $3.52 in pre-market trading after gaining around 7% on Friday. BigBear.AI recently announced a $25 million private placement.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 30, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

January 30, 2023

We're starting off the week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday!

Via InvestorPlace

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 27, 2023

Via Benzinga

Dow Gains Over 100 Points; Eastern Bankshares Shares Drop After Q4 Results ↗

January 27, 2023

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 1% on Friday. The Dow traded up 0.41% to 34,088.68 while the NASDAQ rose 1.27% to 11,659.16. The S&P 500...

Via Benzinga

Why Applied UV Shares Are Trading Higher By 46%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 27, 2023

Gainers FOXO Technologies Inc. (NYSE: FOXO) shares jumped 109% to $1.07. Akanda Corp. (NASDAQ: AKAN) rose 59% to $0.4459 after jumping 47% on Thursday.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Quince Therapeutics, Inc. - Common Stock (NQ:QNCX)

All News about Quince Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today